# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-026831
Filing Date
2023-05-26
Accepted
2023-05-26 08:00:13
Documents
4
Period of Report
2023-06-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20008170x1_def14a.htm | DEF 14A | 611375
2 |  | logo_prokidney.jpg | GRAPHIC | 41148
3 |  | ny20008170x1_pc01.jpg | GRAPHIC | 493261
4 |  | ny20008170x1_pc02.jpg | GRAPHIC | 476262
| Complete submission text file | 0001140361-23-026831.txt |  | 2003548

Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40560 | Film No.: 23963105
SIC: 2836 Biological Products, (No Diagnostic Substances)